Syndax Pharmaceuticals, Inc. (SNDX)
19.35
+0.06
(+0.31%)
USD |
NASDAQ |
Sep 01, 10:21
Syndax Pharmaceuticals Cash from Operations (Annual) : -322.98M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -322.98M |
| December 31, 2024 | -274.90M |
| December 31, 2023 | -160.60M |
| December 31, 2022 | -133.68M |
| December 31, 2021 | 29.13M |
| December 31, 2020 | -71.26M |
| December 31, 2019 | -50.61M |
| December 31, 2018 | -68.53M |
| Date | Value |
|---|---|
| December 31, 2017 | -47.37M |
| December 31, 2016 | -35.16M |
| December 31, 2015 | -2.428M |
| December 31, 2014 | -14.39M |
| December 31, 2013 | -7.295M |
| December 31, 2012 | -9.284M |
| December 31, 2011 | -10.02M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Viking Therapeutics, Inc. | -278.68M |
| Kura Oncology, Inc. | -64.06M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |